Xanthelasma — SCE Dermatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Check a lipid profile and cardiovascular risk; explain treatment recurrence
Explanation lettering: E = shown as A · C = shown as B · D = shown as C · B = shown as D · A = shown as E
E is correct. Xanthelasma is usually a clinical diagnosis and may occur despite a normal lipid profile, but its presence should prompt lipid and broader cardiovascular-risk assessment. Management of any dyslipidaemia is driven by cardiovascular risk rather than a promise that plaques will regress. Lesion-directed options are elective and recurrence is common, so expectations and risks near the eyelid should be discussed. Symmetry does not establish normal lipids, routine bilateral biopsy is unnecessary in a typical presentation, statins do not reliably erase existing plaques, and exhaustive genetic investigation is not required in every patient. Atypical morphology would change the diagnostic approach.
Reference: DermNet xanthoma and xanthelasma review: https://dermnetnz.org/topics/xanthoma